{
  "trial_id": "NCT00266695",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, baseline visual acuity, HbA1c levels, blood pressure, body mass index (BMI), previous treatments for diabetic retinopathy, duration since completion of B7A-MC-MBCM study, baseline severity of diabetic retinopathy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Duration of Diabetes",
          "duration of diabetes"
        ],
        [
          "Visual Acuity (VA) Score",
          "baseline visual acuity"
        ],
        [
          "Blood Pressure",
          "blood pressure"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes Type",
        "Number of Diabetic Retinopathy (DR) Study Eyes Per Participant"
      ],
      "remaining_candidate_features": [
        "HbA1c levels",
        "previous treatments for diabetic retinopathy",
        "duration since completion of B7A-MC-MBCM study",
        "baseline severity of diabetic retinopathy"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Visual Acuity, Duration of Diabetes, HbA1c, Blood Pressure, Prior Treatment for Diabetic Retinopathy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Duration of Diabetes",
          "Duration of Diabetes"
        ],
        [
          "Blood Pressure",
          "Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Diabetes Type",
        "Body Mass Index",
        "Number of Diabetic Retinopathy (DR) Study Eyes Per Participant",
        "Visual Acuity (VA) Score"
      ],
      "remaining_candidate_features": [
        "Baseline Visual Acuity",
        "HbA1c",
        "Prior Treatment for Diabetic Retinopathy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Diabetes duration, Previous cardiovascular disease (CVD) event, Glycated hemoglobin, Blood pressure, Cholesterol, Triglycerides,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Race/Ethnicity",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Duration of Diabetes",
          "Diabetes duration"
        ],
        [
          "Blood Pressure",
          "Blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Diabetes Type",
        "Body Mass Index",
        "Number of Diabetic Retinopathy (DR) Study Eyes Per Participant",
        "Visual Acuity (VA) Score"
      ],
      "remaining_candidate_features": [
        "Previous cardiovascular disease (CVD) event",
        "Glycated hemoglobin",
        "Cholesterol",
        "Triglycerides"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, duration of diabetes, type of diabetes, HbA1c, blood pressure, body mass index (BMI), smoking status, diabetic retinopathy severity, visual acuity, prior diabetic retinopathy treatments, prior ruboxistaurin exposure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Diabetes Type",
          "type of diabetes"
        ],
        [
          "Duration of Diabetes",
          "duration of diabetes"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Visual Acuity (VA) Score",
          "visual acuity"
        ],
        [
          "Blood Pressure",
          "blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Number of Diabetic Retinopathy (DR) Study Eyes Per Participant"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "HbA1c",
        "smoking status",
        "diabetic retinopathy severity",
        "prior diabetic retinopathy treatments",
        "prior ruboxistaurin exposure"
      ]
    }
  }
}